Skip to main content
Premium Trial:

Request an Annual Quote

Lori Batta

Lori Batta has been promoted to chief commercial officer of Celmatix. Previously, she was the company's senior vice president of sales. Prior to joining Celmatix, Batta was senior vice president of business development and strategic alliances at Good Start Genetics, and before that, she held senior roles at MDR Specialty Pharmacy, EMD Serono, and Novartis.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.